Acne Asthma Drug Fails to Help Patients with Acne
Below is a MRR and PLR article in category Health Fitness -> subcategory Acne.
Acne: Asthma Drug Ineffective for Severe Acne Treatment
Summary
A mid-stage trial by Critical Therapeutics Inc. revealed that the asthma medication Zyflo, or zileuton, is ineffective in treating severe acne. The drug performed no better than a placebo in reducing inflammatory lesions.Article
In a recent trial, the asthma medication Zyflo, also known as zileuton, was tested as a treatment for severe acne. Unfortunately, the results were not promising. Conducted by Critical Therapeutics Inc., the trial showed that Zyflo did not outperform a placebo in reducing the number of inflammatory lesions.
Over the course of the 12-week study, patients using Zyflo had an average reduction of 11.5 inflammatory lesions. In comparison, those taking a placebo experienced a reduction of 9.1 lesions, which was not statistically significant.
While patients on the placebo showed a decrease of 16.4 total lesions, Zyflo users saw a mean reduction of 25.3 lesions. Despite this, the primary goal of the trial was not met, as the drug did not significantly surpass the effectiveness of the placebo.
Linda Lennox, a company spokesperson, mentioned that despite failing to meet the primary objective, the study hinted at a potential benefit for some patients. Consequently, the company plans to conduct a larger trial using insights gained from this "proof of concept" study.
Based in Lexington, Massachusetts, the company continues to analyze the data and collaborate with investigators for further insights. Zyflo, which inhibits the inflammation-causing enzyme 5-lipoxygenase (5-LO), received approval in 1996 for asthma patients aged 12 and older. Initially owned by Abbott Laboratories Inc., it was licensed to Critical Therapeutics in 2003.
You can find the original non-AI version of this article here: Acne Asthma Drug Fails to Help Patients with Acne.
You can browse and read all the articles for free. If you want to use them and get PLR and MRR rights, you need to buy the pack. Learn more about this pack of over 100 000 MRR and PLR articles.